Overview

Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

We want to investigate if early follicular phase downregulation and androgen priming, by use of GnRH antagonist, aromatase inhibitor and hCG before COH in a short protocol, shows signs of improvement compared to standard short antagonist protocol

Phase:

Phase 4

Details

Lead Sponsor:

Rigshospitalet, Denmark

Treatments:

Androgens
Aromatase Inhibitors